Evidence mapPaperPMID 41521729Full record

SynthesisNutrition reviews2026

Effects of Vitamin C and/or E Supplementation on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes: A Systematic Review and Subgroup Meta-analysis.

Jerónimo Aragón-Vela, Jesús R Huertas, Rafael A Casuso

Abstract readSystematic ReviewMeta-Analysis
In one paragraph

Synthesis in Nutrition reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jerónimo Aragón-VelaDepartment of Health Sciences, Area of Physiology, University of Jaén, 23071 Jaén, Spain.ORCID 0000-0002-2550-6695
Jesús R HuertasInstitute of Nutrition and Food Technology, Department of Physiology, University of Granada, 18071 Granada, Spain.ORCID 0000-0002-7446-0857
Rafael A CasusoDepartment of Health Sciences, Universidad Loyola Andalucía, 14004 Córdoba, Spain.ORCID 0000-0002-4482-3186

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextType 2 diabetes (T2D) is one of the fastest-growing global health emergencies of the 21st century. However, high antioxidant capacity of supplementation of vitamin C and/or E was inversely associated with insulin resistance. However, each antioxidant possesses a distinct biological function that may be influenced by both dosage and duration of supplementation, potentially resulting in significantly different effects.

objectiveThis meta-analysis aimed to evaluate whether vitamin C, vitamin E, or their combination is more effective in improving glycemic control, blood lipids, and blood pressure in individuals with T2D. DATA SOURCES AND DATA EXTRACTION: A systematic search was conducted in PubMed, Scopus, and Web of Science databases for randomized clinical trials, identifying 52 studies (n = 1425 participants). DATA ANALYSIS: Random-effects models were used to assess the effects of vitamin C and/or E supplementation on glycemic control, blood lipid levels, and blood pressure. These findings indicate that supplementation with vitamin C, vitamin E, or their combination has a comparable effect on glycemic index values, systolic blood pressure, and blood lipid profiles. However, a significant reduction in systolic blood pressure was observed only with vitamin C and combined vitamin C + E supplementation. Additionally, a significant increase in high-density-lipoprotein (HDL) levels was noted exclusively with the combined vitamin C + E supplementation.

conclusionConsequently, supplementation with vitamin C, vitamin E, and their combination (C + E) exhibited differing effects on HDL levels and systolic blood pressure. However, their effects on glycemic control, diastolic blood pressure, and blood lipids other than HDL were comparable. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration no. CRD42023399366.

Indexed as

Ascorbic AcidCardiovascular DiseasesDiabetes Mellitus, Type 2Dietary SupplementsGlycemic ControlVitamin EAntioxidantsBlood GlucoseBlood PressureHeart Disease Risk FactorsHumansLipidsRandomized Controlled Trials as TopicAntioxidantsAscorbic AcidBlood GlucoseLipidsVitamin Ealpha-tocopherolascorbic acidHDLsystolic blood pressure

Identifiers

PMID41521729
PMCPMC12793614

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.